It has been demonstrated that TAK-147 is more potent and brain-specific AChE inhibition than tacrine and physostigmine, and has been approval potentiating choline acetyltransferase ( ChAT ) activity in cultured rat septal neurons more potent than donepezil, tacrine and revastigmine.